Lumoxiti

Medicinal product

(Invented) name

Lumoxiti

Active substance (s)

Moksetumomabas pasudotoksas

Strength

1 mg

Pharmaceutical form

milteliai koncentratui ir tirpalas infuziniam tirpalui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01FB02, moxetumomab pasudotox

Marketing authorisation holder

AstraZeneca AB, Švedija

Date of authorisation

2021-02-08

Date of renewal

Documents

Search in EMA Europe

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Powder for concentrate and solution for solution for infusion	1 vnt.
Moksetumomabas pasudotoksas	1 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
106030	92131	1092131	flakonas	N2+N1		Receptinis	EU/1/20/1522/001	Netiekiama	-	-	No	-	-
106031	92132	1092132	flakonas	N3+N1		Receptinis	EU/1/20/1522/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2021-08-01	Išregistruotas
2021-02-08	Registruotas